INSP's Inspire V gains traction with strong clinical data, improving reimbursement visibility and cost control, even as inventory and GLP-1 headwinds persist.
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Inspire Medical Systems, Inc. (INSP) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
Inspire Medical Systems' stock recently saw a significant surge, reacting to news that appears to be important. But does the increase from yesterday indicate that this is a good time to buy, or are we merely trying to catch a falling knife?
The maker of an implant to treat sleep apnea receives an upgrade to Buy from Hold at Stifel.
Inspire Medical Systems, Inc. ( INSP ) UBS Global Healthcare Conference 2025 November 10, 2025 11:45 AM EST Company Participants Timothy Herbert - Founder, Chairman, CEO & President Ezgi Yagci - Vice President of Investor Relations Conference Call Participants Danielle Antalffy - UBS Investment Bank, Research Division Presentation Danielle Antalffy UBS Investment Bank, Research Division All right. Good morning, everyone.
Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves, with full-year EPS guidance raised.
Baron Discovery Fund ended the quarter up 2.85% but underperformed its benchmark, the Russell 2000 Growth Index. Leading defense technology provider Kratos Defense & Security Solutions contributed to performance following a strong earnings report and continued momentum across its business segments. PAR Technology's shares fell during the quarter after the company lowered its full-year growth outlook to 15% from 20%.
Inspire Medical Systems, Inc. ( INSP ) Q3 2025 Earnings Call November 3, 2025 5:00 PM EST Company Participants Ezgi Yagci - Vice President of Investor Relations Timothy Herbert - Founder, Chairman, CEO & President Richard Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities, Research Division Adam Maeder - Piper Sandler & Co., Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Danielle Antalffy - UBS Investment Bank, Research Division David Rescott - Robert W. Baird & Co. Incorporated, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Anthony Petrone - Mizuho Securities USA LLC, Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Daniel Markowitz - Evercore ISI Institutional Equities, Research Division Michael Sarcone - Jefferies LLC, Research Division Christopher Pasquale - Nephron Research LLC Richard Newitter - Truist Securities, Inc., Research Division Brett Fishbin - KeyBanc Capital Markets Inc., Research Division Michael Polark - Wolfe Research, LLC Michael Kratky - Leerink Partners LLC, Research Division Presentation Operator Good afternoon.
Inspire Medical Systems (INSP) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of a loss of $0.15 per share. This compares to earnings of $0.6 per share a year ago.
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?